Effectiveness of bortezomib in multiple myeloma: Preliminary results from an international electronic observational study

被引：0
|
作者：
Delforge, M. [1 ]
Katodritou, E. [2 ]
Zervas, K. [2 ]
Sargin, D. [3 ]
Hulin, C. [4 ]
Linderholm, M. [5 ]
Verrou, E. [2 ]
Poon, V [6 ]
Dhawan, R. [6 ]
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Theagenion Canc Ctr, Thessaloniki, Greece
[3] Istanbul Univ, Istanbul, Turkey
[4] CHU NANCY Brabois, Nancy, France
[5] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[6] Johnson & Johnson Pharmaceut Serv, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70183-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [41] Carfilzomib-Lenalidomide-Dexamethasone Versus Bortezomib-Lenalidomide-Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Results from the Prospective, Longitudinal, Observational Commpass Study
    Landgren, Ola
    Siegel, David S.
    Auclair, Daniel
    Chari, Ajai
    Boedigheimer, Michael
    Welliver, Tim
    Mezzi, Khalid
    Iskander, Karim
    Jakubowiak, Andrzej
    BLOOD, 2018, 132
  • [42] RESULTS OF A RANDOMIZED, PHASE II STUDY OF BEVACIZUMAB AND BORTEZOMIB VS. BORTEZOMIB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: AMBER STUDY
    White, D.
    Kassim, A.
    Bhaskar, B.
    Xing, B.
    Wamstad, K.
    Paton, V.
    ANNALS OF ONCOLOGY, 2010, 21 : 351 - 352
  • [43] A MULTINATIONAL OBSERVATIONAL STUDY IN MULTIPLE MYELOMA (PREAMBLE): INITIAL RESULTS OF TREATMENT PATTERNS
    Vij, R.
    Annemans, L.
    Goldschmidt, H.
    Moreau, P.
    Cook, G.
    Palumbo, A.
    Durie, B.
    Cella, D.
    Reece, D.
    Bartlett, J. B.
    Le, T. K.
    Davis, C.
    HAEMATOLOGICA, 2014, 99 : 372 - 373
  • [44] Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.
    Wu, Wenjun
    Zheng, Gaofeng
    Han, Xiaoyan
    Zhao, Yi
    He, Donghua
    Yang, Yang
    He, Jingsong
    Zheng, Weiyan
    Sun, Jie
    Shi, Jimin
    Wei, Guoqing
    Huang, He
    Cai, Zhen
    BLOOD, 2015, 126 (23)
  • [45] An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival
    Cook, Gordon
    Cella, David
    Durie, Brian
    Goldschmidt, Hartmut
    Kuter, David
    Moreau, Philippe
    Vij, Ravi
    Davis, Catherine
    Oukessou, Abderrahim
    Zyczynski, Teresa
    Popov, Sergey
    Palumbo, Antonio
    BLOOD, 2015, 126 (23)
  • [46] An ongoing multinational observational study in multiple myeloma (PREAMBLE): Preliminary report on patient survival
    Cook, G.
    Cella, D.
    Durie, B.
    Goldschmidt, H.
    Kuter, D.
    Moreau, P.
    Vij, R.
    Davis, C.
    Oukessou, A.
    Zyczynski, T.
    Popov, S.
    Palumbo, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 111 - 112
  • [47] Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS.
    Corso, Alessandro
    Mangiacavalli, Silvia
    Cocito, Federica
    Pascutto, Cristiana
    Astori, Cesare
    Varettoni, Marzia
    Orlandi, Ester
    Zappasodi, Patrizia
    Rizzi, Silvia
    Ambaglio, Ilaria
    Lazzarino, Mario
    Cazzola, Mario
    BLOOD, 2010, 116 (21) : 1252 - 1252
  • [48] Bortezomib in relapsed or refractory multiple myeloma:: results in a cohort of 39 patients
    Canovas Fernandez, A.
    Alonso Alonso, J. J.
    Barreiro Garcia, J. G.
    Aguirre Errasti, C.
    REVISTA CLINICA ESPANOLA, 2008, 208 (04): : 187 - 192
  • [49] Bortezomib plus dexamethasone as induction therapy in newly diagnosed multiple myeloma: A preliminary study in thai patients
    Nakorn, T. Na
    Watanaboonyongcharoen, P.
    Niparuck, P.
    Chancharunee, S.
    Intragumtomchai, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 411 - 411
  • [50] Phase III results of bortezomib use in previously untreated multiple myeloma
    不详
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (01) : 14 - 14
12345